University Operating Status

Grateful for care received from Rutgers doctors, the New Jersey executive provides support in four crucial research areas

After undergoing quadruple bypass surgery more than two decades ago, telehealth pioneer James Tuchi took an interest in the research his doctors were doing.

Tuchi, an early innovator in the burgeoning field of online medical care as CEO and founder of Millennium Healthcare Solutions, resolved to champion their work whenever possible. He recently committed $8 million in support of major initiatives at Rutgers Biomedical and Health Sciences (RBHS) and the Rutgers School of Communication and Information. 

The gift will propel advances in biohazard management, medical device development, post-trauma care and crisis communication. It also will help develop avenues for health care-related mentoring, information sharing and clinical trial incubation.

Tuchi and his wife, Sari, New Brunswick residents, both received life-saving treatments from experts at Rutgers Robert Wood Johnson Medical School. Since his surgery in 1994, Tuchi remained under the care of Clifton R. Lacy, the former New Jersey health commissioner and former chief of cardiology at Rutgers Robert Wood Johnson Medical School. 
 
Lacy, now a Distinguished Professor in the School of Communication and Information, introduced Tuchi to his primary care physician, Jeffrey Carson, provost of Rutgers Biomedical and Health Sciences.

“If not for them and the people at Robert Wood Johnson, I wouldn’t be in the shape I’m in,” said Tuchi, who continued his involvement in the pharmaceutical and life science industries at Global Health Sciences, Inc., which he also founded.

One of Tuchi’s philanthropic goals was to find “programs that could be immediately beneficial if they had funding.” RBHS chancellor Brian Strom agreed that the influence of these initiatives will be almost immediate but will “also have impact for many, many years.”

Tuchi’s gift includes $3 million to drive advances in the management of mass exposure to anthrax; develop a portable device that detects lead in water and blood; improve bleeding control after traumatic injuries; and train leaders in effective risk and crisis communication. These efforts are led by Lacy, who lauded “the acceleration of discovery, innovation and development right here at Rutgers” and said that Tuchi’s generosity will have “a multiplier effect for a long time to come.” 

Another $3 million will launch a clinical trial incubator headed by Carson, the Richard C. Reynolds M.D. Chair in General Internal Medicine. The incubator will guide and train faculty seeking to redirect their careers into medical research, giving professionals “the tools necessary to succeed, build the capacity of faculty to initiate high-impact research, and bring important research projects to the university,” Carson said.

Finally, $2 million will support Project ECHO, a guided-practice, tele-mentoring model, comprising telehealth clinics in which practitioners across a variety of disciplines exchange information and insight. “ECHO allows participants to share best practices,” said Kathy Dodsworth-Rugani, the project’s executive director. “It is an all-teach, all-learn model to enable better access to health care for all.”

Chancellor Strom praised Tuchi for empowering advances “on many different levels.” Strom said the benefits will be visible “in terms of providing care to patients who otherwise wouldn't get it, and to future generations and new discoveries going forward.”